icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Plasma Metabolites for de Novo Lipogenesis and Pharmacodynamic Activity of Acetyl-CoA Carboxylase Inhibitor GS-0976
 
 
  Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
 
Jacqueline M. Tarrant,1 Mona Vimal,1 Klaus-Peter Adam,2 Deirdre Hauser,2 Haibao Wan,2 Ren Xu,1 Brian J. Kirby,1 Cara Nelson,1 Adrian S. Ray,1 Ting Wang,1
Kathryn Stiede,3 William F. Westlin,3 C. Stephen Djedjos,1 Bryan J. McColgan,1 Scott D. Patterson,1 Tuan Nguyen,1 Robert P. Myers1
1Gilead Sciences, Inc., Foster City, CA; 2Metabolon, Inc., Morrisville, NC; 3Nimbus Therapeutics, Cambridge, MA

AASDL1

AASDL2

AASDL3

AASDL4

AASDL5

AASDL6